September 12, 2023
September 1, 2023
January 18, 2021
November 19, 2020
October 6, 2018
January 19, 2018
May 30, 2017
Mederi Therapeutics announced highlights of educational activities on Stretta Therapy for Gastroesophageal Reflux Disease (GERD) that took place at Digestive Disease Week® 2017 (DDW 2017). The activities included a presentation on "Unmet Needs in GERD Treatment", presented by Dr. Ronnie Fass and Professor Jan Tack. The presentation featured data from the new Stretta Meta-Analysis as well as data on mechanism and GERD outcome measures.
June 13, 2016
Mederi Therapeutics, Inc., manufacturers of Stretta Therapy for GERD, today announced that a new study, published in Managed Care, suggests the potential for substantial payer cost savings associated with radiofrequency energy (RFE) treatment of GERD patients, as compared to treatment with medical management or fundoplication.
June 13, 2016
Stretta clinical data presented at DDW2016 shows effectiveness in challenging GERD patient populations: Obese patients, laryngopharyngeal reflux (LPR) symptoms, GERD post-nissen. DDW activities also included the launch of the new Stretta RFT3 system and four presentations by international Stretta expert physicians.